Literature DB >> 23030513

Clinical epidemiology of ALS in Liguria, Italy.

Monica Bandettini di Poggio1, Maria Pia Sormani, Romina Truffelli, Paola Mandich, Paola Origone, Simonetta Verdiani, Vittorio Mantero, Carlo Scialò, Angelo Schenone, Giovanni Luigi Mancardi, Claudia Caponnetto.   

Abstract

Our objective was to assess the incidence and trends of amyotrophic lateral sclerosis (ALS) in Liguria, a north-west region of Italy, utilizing a prospective design. Liguria (1,615,064 residents in 2010) is the site of a multicentre-multisource prospective population based registry called LIGALS (Liguria Amyotrophic Lateral Sclerosis Registry). All incident ALS cases during the period 2009-2010 were enrolled and followed up. Cases were identified using several concurrent sources. ALS diagnosis was based on the revised El Escorial criteria. One hundred and four cases were enrolled, generating an annual crude incidence of 3.22/100,000 (95% CI 2.66-3.90), with a male/female ratio of 1.34. The annual standardized incidence, age and gender adjusted to the 2001 Italian population, was 2.51. At last observation on 1 March 2012, 45% of patients registered in the LIGALS had died, with a median survival of 45 months from symptoms onset. According to capture-recapture estimation, three patients were unobserved. For both genders, demographic and clinical features were collected. In conclusion, comparing these data to those of epidemiological studies with a similar prospective design, the occurrence of ALS is similar. The observed crude incidence was higher compared to other Italian studies, due in part to a very careful case ascertainment and in part to a high percentage of the elderly in Liguria.

Entities:  

Mesh:

Year:  2012        PMID: 23030513     DOI: 10.3109/17482968.2012.729062

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  10 in total

Review 1.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

Review 2.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

3.  Factors predicting survival in ALS: a multicenter Italian study.

Authors:  Andrea Calvo; Cristina Moglia; Christian Lunetta; Kalliopi Marinou; Nicola Ticozzi; Gianluca Drago Ferrante; Carlo Scialo; Gianni Sorarù; Francesca Trojsi; Amelia Conte; Yuri M Falzone; Rosanna Tortelli; Massimo Russo; Adriano Chiò; Valeria Ada Sansone; Gabriele Mora; Vincenzo Silani; Paolo Volanti; Claudia Caponnetto; Giorgia Querin; Maria Rosaria Monsurrò; Mario Sabatelli; Nilo Riva; Giancarlo Logroscino; Sonia Messina; Nicola Fini; Jessica Mandrioli
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

4.  Stratification of ALS patients' survival: a population-based study.

Authors:  Benoît Marin; Philippe Couratier; Simona Arcuti; Massimiliano Copetti; Andrea Fontana; Marie Nicol; Marie Raymondeau; Giancarlo Logroscino; Pierre Marie Preux
Journal:  J Neurol       Date:  2015-10-30       Impact factor: 4.849

5.  Age-specific ALS incidence: a dose-response meta-analysis.

Authors:  Benoît Marin; Andrea Fontana; Simona Arcuti; Massimilano Copetti; Farid Boumédiene; Philippe Couratier; Ettore Beghi; Pierre Marie Preux; Giancarlo Logroscino
Journal:  Eur J Epidemiol       Date:  2018-04-23       Impact factor: 8.082

Review 6.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

7.  PRISM: a novel research tool to assess the prevalence of pseudobulbar affect symptoms across neurological conditions.

Authors:  Benjamin Rix Brooks; David Crumpacker; Jonathan Fellus; Daniel Kantor; Randall E Kaye
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

8.  Molecular Chaperones in the Pathogenesis of Amyotrophic Lateral Sclerosis: The Role of HSPB1.

Authors:  Simona Capponi; Thomas Geuens; Alessandro Geroldi; Paola Origone; Simonetta Verdiani; Elena Cichero; Elias Adriaenssens; Vicky De Winter; Monica Bandettini di Poggio; Marco Barberis; Adriano Chiò; Paola Fossa; Paola Mandich; Emilia Bellone; Vincent Timmerman
Journal:  Hum Mutat       Date:  2016-08-30       Impact factor: 4.878

9.  Referral bias in ALS epidemiological studies.

Authors:  Giancarlo Logroscino; Benoit Marin; Marco Piccininni; Simona Arcuti; Adriano Chiò; Orla Hardiman; James Rooney; Stefano Zoccolella; Philippe Couratier; Pierre-Marie Preux; Ettore Beghi
Journal:  PLoS One       Date:  2018-04-16       Impact factor: 3.240

Review 10.  Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.

Authors:  Benoît Marin; Farid Boumédiene; Giancarlo Logroscino; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Massimilano Copetti; Pierre-Marie Preux; Ettore Beghi
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.